Aurobindo Pharma Has one of the broadest API portfolios between Indian pharmaceutical businesses, with about 200 APIs. It is actually a number one world-wide manufacturer of semi-artificial penicillins and maintains a solid existence in anti-retrovirals and cardiovascular APIs. The business’s vertically built-in design provides considerable Price tag benefits. US scoped https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html